TNF and rheumatoid arthritis: Standard therapy for RA includes methotrexate and one of several disease-modifying anti-rheumatic drugs (DMARDs) that target the key inflammatory molecules that promote RA, including TNFα (infliximab, etanercept) and IL6 (tocilizumab).